BioCentury | May 9, 2016
Product Development

Community organizers

With new papers published by the day and a flurry of big-dollar deals and financings, it's hard to separate the signal from the noise in the microbiome space. The space has become so hot that...
BC Week In Review | Mar 7, 2016
Clinical News

Blautix: Completed Phase I enrollment

4D completed enrollment of 56 healthy volunteers and patients in a Phase I trial of Blautix. 4D Pharma plc (LSE:DDDD), Manchester, U.K.   Product: Blautix   Business: Gastrointestinal   Molecular target: NA   Description: Live...
Items per page:
1 - 2 of 2